"Herpesvirus 1, Human" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions.
MeSH Number(s)
B04.280.382.100.750.390
B04.909.204.382.100.750.390
Concept/Terms
Herpesvirus 1, Human- Herpesvirus 1, Human
- Herpes Simplex Virus 1
- Human herpesvirus 1
- HHV-1
- HSV-1
- Herpes Simplex Virus Type 1
- Herpesvirus 1 (alpha), Human
Below are MeSH descriptors whose meaning is more general than "Herpesvirus 1, Human".
Below are MeSH descriptors whose meaning is more specific than "Herpesvirus 1, Human".
This graph shows the total number of publications written about "Herpesvirus 1, Human" by people in Harvard Catalyst Profiles by year, and whether "Herpesvirus 1, Human" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 2 | 1 | 3 |
1994 | 15 | 3 | 18 |
1995 | 8 | 1 | 9 |
1996 | 13 | 2 | 15 |
1997 | 12 | 2 | 14 |
1998 | 15 | 1 | 16 |
1999 | 16 | 4 | 20 |
2000 | 24 | 4 | 28 |
2001 | 17 | 8 | 25 |
2002 | 16 | 5 | 21 |
2003 | 20 | 5 | 25 |
2004 | 16 | 6 | 22 |
2005 | 12 | 3 | 15 |
2006 | 17 | 1 | 18 |
2007 | 15 | 3 | 18 |
2008 | 17 | 2 | 19 |
2009 | 10 | 4 | 14 |
2010 | 13 | 2 | 15 |
2011 | 11 | 4 | 15 |
2012 | 10 | 5 | 15 |
2013 | 10 | 3 | 13 |
2014 | 9 | 5 | 14 |
2015 | 10 | 5 | 15 |
2016 | 14 | 2 | 16 |
2017 | 7 | 4 | 11 |
2018 | 9 | 10 | 19 |
2019 | 11 | 6 | 17 |
2020 | 2 | 10 | 12 |
2021 | 12 | 7 | 19 |
2022 | 6 | 0 | 6 |
2023 | 1 | 0 | 1 |
Below are the most recent publications written about "Herpesvirus 1, Human" by people in Profiles.
-
Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Sci Transl Med. 2023 Jan 04; 15(677):eabo4778.
-
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clin Cancer Res. 2022 12 15; 28(24):5419-5430.
-
Using CSF Proteomics to Investigate Herpesvirus Infections of the Central Nervous System. Viruses. 2022 Dec 10; 14(12).
-
Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity. Nat Cancer. 2022 11; 3(11):1318-1335.
-
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma. J Clin Oncol. 2023 Jan 20; 41(3):528-540.
-
A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D. Antiviral Res. 2022 05; 201:105298.
-
Prospective investigation of herpesvirus infection and risk of glioma. Int J Cancer. 2022 07 15; 151(2):222-228.
-
The US3 Kinase of Herpes Simplex Virus Phosphorylates the RNA Sensor RIG-I To Suppress Innate Immunity. J Virol. 2022 02 23; 96(4):e0151021.
-
The Astrocyte Type I Interferon Response Is Essential for Protection against Herpes Simplex Encephalitis. J Virol. 2022 02 23; 96(4):e0178321.
-
Deep Herpes. Am J Surg Pathol. 2021 10 01; 45(10):1357-1363.